Abstract
BackgroundIt is commonly accepted that additional methotrexate (MTX) does not increase efficacy for treatment with TNF in psoriatic arthritis (PsA) but concomitant MTX has been also associated with increased drug...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
